Jabbour SA - Search Results

1

SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.

Jabbour SA. Jabbour SA. Postgrad Med. 2014 Jan;126(1):111-7. doi: 10.3810/pgm.2014.01.2731. Postgrad Med. 2014. PMID: 24393758 Review.

2

Uncontrolled diabetes mellitus.

Jabbour SA, Miller JL. Jabbour SA, et al. Clin Lab Med. 2001 Mar;21(1):99-110. Clin Lab Med. 2001. PMID: 11321939 Review.

3

Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition.

Wu X, Hardy VE, Joseph JI, Jabbour S, Mahadev K, Zhu L, Goldstein BJ. Wu X, et al. Metabolism. 2003 Jun;52(6):705-12. doi: 10.1016/s0026-0495(03)00065-9. Metabolism. 2003. PMID: 12800095

4

Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.

Rosenberg DE, Jabbour SA, Goldstein BJ. Rosenberg DE, et al. Among authors: jabbour sa. Diabetes Obes Metab. 2005 Nov;7(6):642-53. doi: 10.1111/j.1463-1326.2004.00446.x. Diabetes Obes Metab. 2005. PMID: 16219008 Review.

5

Diabetes knowledge: are resident physicians and nurses adequately prepared to manage diabetes?

Rubin DJ, Moshang J, Jabbour SA. Rubin DJ, et al. Among authors: jabbour sa. Endocr Pract. 2007 Jan-Feb;13(1):17-21. doi: 10.4158/EP.13.1.17. Endocr Pract. 2007. PMID: 17360296

6

Hypoglycemia in hospitalized patients treated with antihyperglycemic agents.

Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S, Gottlieb JE. Varghese P, et al. J Hosp Med. 2007 Jul;2(4):234-40. doi: 10.1002/jhm.212. J Hosp Med. 2007. PMID: 17702035

7

Accuracy of bedside capillary blood glucose measurements in critically ill patients.

Critchell CD, Savarese V, Callahan A, Aboud C, Jabbour S, Marik P. Critchell CD, et al. Intensive Care Med. 2007 Dec;33(12):2079-84. doi: 10.1007/s00134-007-0835-4. Epub 2007 Sep 1. Intensive Care Med. 2007. PMID: 17763842

8

Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.

Jabbour SA, Goldstein BJ. Jabbour SA, et al. Int J Clin Pract. 2008 Aug;62(8):1279-84. doi: 10.1111/j.1742-1241.2008.01829.x. Int J Clin Pract. 2008. PMID: 18705823 Review.

9

A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS.

Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S. Simon B, et al. Int J Clin Pract. 2008 Dec;62(12):1858-63. doi: 10.1111/j.1742-1241.2008.01932.x. Int J Clin Pract. 2008. PMID: 19166434 Clinical Trial.

10

Advantages of extended-release metformin in patients with type 2 diabetes mellitus.

Jabbour S, Ziring B. Jabbour S, et al. Postgrad Med. 2011 Jan;123(1):15-23. doi: 10.3810/pgm.2011.01.2241. Postgrad Med. 2011. PMID: 21293080 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results